Organisation paid for research Program year 2024 Source: CMS Open Payments

Objective Gi LLC

Neither a doctor nor a teaching hospital

Research payments

$1,046,101

169 payments

Through program year 2024, Objective Gi LLC is reported as receiving $1,046,101 in research payments, across 169 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$36,294	1
2023	Research	$1,000	1
2022	Research	$23,525	10
2021	Research	$243,828	45
2020	Research	$303,720	92
2019	Research	$437,735	20

Breakdown

Who paid Research payments · program years 2019–2024

Intercept Pharmaceuticals, Inc. $1,046,101 169 payments

Studies the money was for Research payments · program years 2019–2024

1009742 $741,454 112 payments
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (REVERSE) $243,828 45 payments
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (REVERSE) $60,819 12 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.